CVS Health Corporation (NYSE:CVS) Receives $91.67 Consensus PT from Brokerages

Shares of CVS Health Corporation (NYSE:CVS) have received a consensus recommendation of “Moderate Buy” from the twenty-six brokerages that are currently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $93.7143.

A number of equities analysts recently issued reports on the company. Barclays raised their target price on CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday. Wells Fargo & Company cut their price objective on CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a report on Thursday, November 13th. Wolfe Research lifted their target price on CVS Health from $85.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, December 8th. Argus increased their price target on shares of CVS Health from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Tuesday, November 4th. Finally, Raymond James Financial raised their price target on shares of CVS Health from $75.00 to $90.00 in a research report on Friday, October 31st.

Hedge Funds Weigh In On CVS Health

A number of institutional investors have recently modified their holdings of CVS. SOA Wealth Advisors LLC. raised its position in CVS Health by 36.9% during the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after acquiring an additional 131 shares in the last quarter. Alteri Wealth LLC increased its holdings in shares of CVS Health by 3.2% during the 3rd quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock valued at $316,000 after purchasing an additional 131 shares in the last quarter. Holistic Financial Partners lifted its stake in shares of CVS Health by 4.1% in the 3rd quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock valued at $256,000 after purchasing an additional 133 shares during the period. CYBER HORNET ETFs LLC boosted its holdings in CVS Health by 4.1% during the third quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator’s stock worth $259,000 after buying an additional 134 shares in the last quarter. Finally, Fayez Sarofim & Co grew its position in CVS Health by 2.1% during the third quarter. Fayez Sarofim & Co now owns 6,913 shares of the pharmacy operator’s stock valued at $521,000 after buying an additional 140 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

CVS opened at $79.45 on Wednesday. The company has a market cap of $100.85 billion, a P/E ratio of 209.08, a price-to-earnings-growth ratio of 0.80 and a beta of 0.48. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The firm’s 50-day moving average price is $78.97 and its 200-day moving average price is $71.83. CVS Health has a 52-week low of $43.56 and a 52-week high of $85.15.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. CVS Health’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities analysts anticipate that CVS Health will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio is presently 700.00%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.